Author:
Raffa R. B.,Shank R. P.,Vaught J. L.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Arvidsson L-E, Hacksell U, Nilsson JLG, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstrom H (1981) 8-Hydroxy-2-(di-n-propyamino)tertralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J Med Chem 24:921–923
2. Bossier JR, Portmann-Cristesco E, Soubrie P, Fichelle J (1974) Pharmacological and biochemical features of trazodone. In: Ban TA, Silverstrini B (eds) Trazodone, modern problems of pharmacopsychiatry, vol 9. Karger, Basel, pp 18–28
3. Brogden RN, Heel RC, Speight TM, Avery GS (1981) Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs 21:401–429
4. Caccia S, Ballabio M, Samanin R, Zanini MG, Garattini S (1981) (-)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone. J Pharm Pharmacol 33:477–478
5. Cheng Y-C, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of the inhibitor which causes 50 percent inhibition (I50) on an enzyme reaction. Biochem Pharmacol 22:3099–3108
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献